Filing Flows

Filing Flows › Treace Medical Concepts (TMCI) › Next earnings date

Treace Medical Concepts (TMCI) earnings: beat the estimate

Treace Medical Concepts (TMCI) reported on Nov 6, 2026 and beat the EPS estimate: −$0.15 against −$0.25 (+39.8%). Revenue was $48.3M for Q3 2026, -4% year over year. It beat the EPS estimate in 100% of the quarters on record.

Last result+39.8% vs estimate
Beat rate100%

The last report

Treace Medical Concepts reported revenue of $48.3M for the third quarter 2026 (-4% Y/Y), net loss $12.6M. How it makes money → · Every quarter →

Treace Medical Concepts: EPS against the estimate, last 5 reportsTreace Medical Concepts: EPS against the estimate, last 5 reportsEstimateReported−$0.27−$0.22Nov 25−$0.14−$0.08Feb 26−$0.31−$0.12May 26−$0.30−$0.20Aug 26−$0.25−$0.15Nov 26
Latest (Nov 26): Estimate −$0.25, Reported −$0.15.

Treace Medical Concepts' latest quarter

Treace Medical Concepts, Q3 2026: revenue $48.3M (-4% year over year), operating margin -23.9%, net loss $12.6M, operating cash flow −$3.3M. The chart follows the revenue to costs, profit and cash.

Questions

Did Treace Medical Concepts beat earnings?

Treace Medical Concepts (TMCI) reported on Nov 6, 2026 and beat the EPS estimate: −$0.15 against −$0.25 (+39.8%).

When does TMCI report earnings?

The next date is not set yet.

Does Treace Medical Concepts usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.